La Mesa, CA8 Active Studies

Ankylosing Spondylitis Clinical Trials in La Mesa, CA

Find 8 actively recruiting ankylosing spondylitis clinical trials in La Mesa, CA. Connect with local research sites and explore new treatment options.

8
Active Trials
5
Sponsors
16,240
Enrolling

Recruiting Ankylosing Spondylitis Studies in La Mesa

RecruitingLa Mesa, CANCT07037433

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

The primary objective of this trial is to demonstrate that maridebart cafraglutide is superior to placebo when given as an adjunct to standard of care with respect to reducing cardiovascular (CV) morb...

12,800 participants
Amgen
View Study Details
RecruitingLa Mesa, CANCT06676319

Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma

This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma. The purpose of this study is to assess the efficacy, safety, and tolerability...

1,000 participants
Sanofi
View Study Details
RecruitingLa Mesa, CANCT04638647

Secukinumab Open Label Roll-over Extension Protocol

The purpose of this study is to assess long term safety in participants who have completed a Novartis trial with secukinumab, have been judged by the investigator to benefit from continued treatment w...

715 participants
Novartis Pharmaceuticals
View Study Details
RecruitingLa Mesa, CANCT06932263

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

This is a dose-range finding, double-blind, placebo-controlled, phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolle...

540 participants
AstraZeneca
View Study Details
RecruitingLa Mesa, CANCT06529419

A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations

A dose range-finding study to assess the efficacy and safety of multiple dose levels of AZD8630 administered via a dry powder inhaler in adults with uncontrolled asthma at risk of exacerbations, recei...

516 participants
AstraZeneca
View Study Details
RecruitingLa Mesa, CANCT06502366

A Study to Investigate the Effect on Lung Function of BDA Formulated With a New Propellant (HFO) Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma

The purpose of this study is to assess the PD equivalence of the approved asthma combination therapy, BDA, delivered using the proposed replacement propellant HFO compared with BDA delivered using the...

398 participants
AstraZeneca
View Study Details
RecruitingLa Mesa, CANCT06749457

A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

The purpose of this study is to evaluate the safety and pharmacokinetics (PK) of AZD7760 when given as an intravenous infusion to healthy participants (Phase I) or participants with end-stage kidney d...

231 participants
AstraZeneca
View Study Details
RecruitingLa Mesa, CANCT06863467

Evaluation of the Safety and Tolerability of Gemini in Subjects With Stage 3-4 Chronic Kidney Disease.

Gemini is being evaluated in a placebo controlled, single dose, escalating dose study to evaluate the safety and tolerability of intravenous Gemini in adult subjects with stage 3 or 4 chronic kidney d...

40 participants
Revelation Biosciences, Inc
View Study Details

About Ankylosing Spondylitis Clinical Trials in La Mesa

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 8 ankylosing spondylitis clinical trials recruiting participants in La Mesa, CA. These studies are seeking a combined 16,240 participants. Research is being sponsored by Amgen, Sanofi, Novartis Pharmaceuticals and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in La Mesa — FAQ

Are there ankylosing spondylitis clinical trials in La Mesa?

Yes, there are 8 ankylosing spondylitis clinical trials currently recruiting in La Mesa, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in La Mesa?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the La Mesa research site will contact you about next steps.

Are clinical trials in La Mesa free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many La Mesa studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 8 active trials in La Mesa are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov